• Something wrong with this record ?

Reductive metabolism of tiaprofenic acid by the human liver and recombinant carbonyl reducing enzymes

P. Malátková, A. Skarka, K. Musilová, V. Wsól,

. 2017 ; 276 (-) : 121-126. [pub] 20170318

Language English Country Ireland

Document type Journal Article

Tiaprofenic acid is a widely used anti-inflammatory drug; however, the reductive metabolism of tiaprofenic acid is not yet well understood. Here, we compared the reduction of tiaprofenic acid in microsomes and cytosol from the human liver. The microsomes exhibited lower Km value toward tiaprofenic acid than the cytosol (Km = 164 ± 18 μM vs. 569 ± 74 μM, respectively), whereas the cytosol showed higher specific activity during reduction than the microsomes (Vmax = 728 ± 52 pmol mg of protein-1 min-1 vs. 285 ± 11 pmol mg of protein-1 min-1, respectively). Next, a panel of recombinant carbonyl reducing enzymes from AKR and SDR superfamilies has been studied to find the enzymes responsible for the cytosolic reduction of tiaprofenic acid. CBR1 was identified as the reductase of tiaprofenic acid with high specific activity (56,965 ± 6741 pmol mg of protein-1 min-1). Three other enzymes, AKR1A1, AKR1B10, and AKR1C4, were also able to reduce tiaprofenic acid, but with very low activity. Thus, CBR1 was shown to be a tiaprofenic acid reductase in vitro and was also suggested to be the principal tiaprofenic acid reductase in vivo.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18016713
003      
CZ-PrNML
005      
20200131094748.0
007      
ta
008      
180515s2017 ie f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.cbi.2017.03.006 $2 doi
035    __
$a (PubMed)28322780
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ie
100    1_
$a Malátková, Petra $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, Hradec Králové, CZ-50005, Czech Republic. Electronic address: petra.malatkova@faf.cuni.cz.
245    10
$a Reductive metabolism of tiaprofenic acid by the human liver and recombinant carbonyl reducing enzymes / $c P. Malátková, A. Skarka, K. Musilová, V. Wsól,
520    9_
$a Tiaprofenic acid is a widely used anti-inflammatory drug; however, the reductive metabolism of tiaprofenic acid is not yet well understood. Here, we compared the reduction of tiaprofenic acid in microsomes and cytosol from the human liver. The microsomes exhibited lower Km value toward tiaprofenic acid than the cytosol (Km = 164 ± 18 μM vs. 569 ± 74 μM, respectively), whereas the cytosol showed higher specific activity during reduction than the microsomes (Vmax = 728 ± 52 pmol mg of protein-1 min-1 vs. 285 ± 11 pmol mg of protein-1 min-1, respectively). Next, a panel of recombinant carbonyl reducing enzymes from AKR and SDR superfamilies has been studied to find the enzymes responsible for the cytosolic reduction of tiaprofenic acid. CBR1 was identified as the reductase of tiaprofenic acid with high specific activity (56,965 ± 6741 pmol mg of protein-1 min-1). Three other enzymes, AKR1A1, AKR1B10, and AKR1C4, were also able to reduce tiaprofenic acid, but with very low activity. Thus, CBR1 was shown to be a tiaprofenic acid reductase in vitro and was also suggested to be the principal tiaprofenic acid reductase in vivo.
650    _2
$a alkoholoxidoreduktasy $x chemie $x genetika $x metabolismus $7 D000429
650    _2
$a biokatalýza $7 D055162
650    _2
$a cytosol $x enzymologie $7 D003600
650    _2
$a lidé $7 D006801
650    _2
$a kinetika $7 D007700
650    _2
$a játra $x enzymologie $x metabolismus $7 D008099
650    _2
$a mikrozomy $x enzymologie $7 D008861
650    _2
$a propionáty $x chemie $x metabolismus $7 D011422
650    _2
$a rekombinantní proteiny $x biosyntéza $x chemie $x izolace a purifikace $7 D011994
650    _2
$a dehydrogenasy/reduktasy s krátkým řetězcem $x chemie $x genetika $x metabolismus $7 D000074583
655    _2
$a časopisecké články $7 D016428
700    1_
$a Skarka, Adam $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, Hradec Králové, CZ-50005, Czech Republic. Electronic address: skara3aa@faf.cuni.cz.
700    1_
$a Musilová, Kateřina, $d 1991- $7 xx0244496 $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, Hradec Králové, CZ-50005, Czech Republic. Electronic address: musilok2@faf.cuni.cz.
700    1_
$a Wsól, Vladimír $u Department of Biochemical Sciences, Faculty of Pharmacy, Charles University, Heyrovského 1203, Hradec Králové, CZ-50005, Czech Republic. Electronic address: vladimir.wsol@faf.cuni.cz.
773    0_
$w MED00002111 $t Chemico-biological interactions $x 1872-7786 $g Roč. 276, č. - (2017), s. 121-126
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28322780 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180515 $b ABA008
991    __
$a 20200131095131 $b ABA008
999    __
$a ok $b bmc $g 1300337 $s 1013553
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 276 $c - $d 121-126 $e 20170318 $i 1872-7786 $m Chemico-biological interactions $n Chem Biol Interact $x MED00002111
LZP    __
$a Pubmed-20180515

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...